SCHEMBL2389884

SCHEMBL2389884

Cc1ccccc1N/N=C1\C(=O)C=Cc2ccccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.42
MAPT P10636 7/20 0.42
HPGD P15428 6/20 0.42
MEN1 O00255 5/20 0.42
KMT2A Q03164 5/20 0.42
KDM4E B2RXH2 4/20 0.42
LMNA P02545 3/20 0.42
IDO1 P14902 2/20 0.42
POLB P06746 2/20 0.42
BCHE P06276 1/20 0.42
PTPRC P08575 1/20 0.42
THRB P10828 1/20 0.42
PKM P14618 1/20 0.42
ALOX15 P16050 1/20 0.42
PTPN1 P18031 1/20 0.42
ACHE P22303 1/20 0.42
CES1 P23141 1/20 0.42
RECQL P46063 1/20 0.42
HSD17B10 Q99714 1/20 0.42
PTPN22 Q9Y2R2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11880063 0.90 MAPT (0.39) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL11876770 0.86 MAPT (0.56) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL2312130 0.86 MAPT (0.56) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL11875491 0.82 MAPT (0.43) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL11877973 0.82 MAPT (0.43) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL340350 0.82 MAPT (0.43) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL19322469 0.81 TP53 (0.42) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL11877584 0.81 TP53 (0.42) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL11877590 0.81 TP53 (0.42) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL332277 0.81 TP53 (0.42) ALDH1A1MAPTHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4713412-A1 HEAT TRANSFER FLUIDS FOR ELECTRIC VEHICLES Prestone Products Corporation (US) 2026-03-25 EP disclosed
US-20250108658-A1 INKJET PRINTING PROCESSES FOR TEMPORARY TATTOOS Prism Inks, Inc. (US) 2025-04-03 US disclosed
WO-2024238497-A1 HEAT TRANSFER FLUIDS FOR ELECTRIC VEHICLES PRESTONE PRODUCTS CORPORATION (US) 2024-11-21 WO disclosed
US-11384033-B2 Compositions with improved urease-inhibiting effect comprising (thio)phosphoric acid triamide and further compounds such as amines and colorants BASF SE (DE) 2022-07-12 US disclosed
CN-107108388-B Composition comprising (thio) phosphoric triamide and other compounds such as amines and colorants with improved urease-inhibiting effect 巴斯夫欧洲公司 2021-02-26 CN disclosed
CN-112374933-A Composition comprising (thio) phosphoric triamide and other compounds such as amines and colorants with improved urease-inhibiting effect 巴斯夫欧洲公司 2021-02-19 CN disclosed
EP-3763692-A1 COMPOSITIONS WITH IMPROVED UREASE-INHIBITING EFFECT COMPRISING (THIO) PHOSPHORIC ACID TRIAMIDE AND FURTHER COMPOUNDS SUCH AS AMINES AND COLORANTS BASF SE (DE) 2021-01-13 EP disclosed
EP-3763691-A1 COMPOSITIONS WITH IMPROVED UREASE-INHIBITING EFFECT COMPRISING (THIO)PHOSPHORIC ACID TRIAMIDE AND FURTHER COMPOUNDS SUCH AS AMINES AND COLORANTS BASF SE (DE) 2021-01-13 EP disclosed
EP-3725756-A2 COMPOSITIONS WITH IMPROVED UREASE-INHIBITING EFFECT COMPRISING AMINES, OR COLORANTS, AND AN ADDUCT OF THE THREE COMPOUNDS N-(N-BUTYL) THIOPHOSPHORIC ACID TRIAMIDE (NBPT), UREA, AND FORMALDEHYDE BASF SE (DE) 2020-10-21 EP disclosed
CN-108663892-B Laser projection display screen containing light absorption layer and preparation method and application thereof 华南理工大学 2020-06-19 CN disclosed
US-20080127429-A1 Coloring composition of keratinous fibers comprising at least one polysiloxane/polyurea block copolymer L'OREAL S.A. (FR) 2008-06-05 US disclosed
US-20070178126-A1 Polyamino acids functionalized by at least one (oligo)amino acid group and therapeutic uses FLAMEL TECHNOLOGIES (FR) 2007-08-02 US disclosed
US-20070160568-A1 Polyamino acids functionalized by at least one hydrophobic group and the therapeutic application thereof FLAMEL TECHNOLOGIES, INC. (FR) 2007-07-12 US disclosed
US-20060099264-A1 Polyaminoacids functionalized by alpha tocopherol and uses thereof, particular for therapeutic applications AVADEL LEGACY PHARMACEUTICALS, LLC 2006-05-11 US disclosed
EP-1567578-A1 POLYAMINO ACIDS FUNCTIONALIZED BY AT LEAST ONE (OLIGO)AMINO ACID GROUP AND THERAPEUTIC USES Flamel Technologies (FR) 2005-08-31 EP disclosed
EP-1525246-A2 POLYAMINO ACIDS FUNCTIONALIZED BY AT LEAST ONE HYDROPHOBIC GROUP AND THE THERAPEUTIC APPLICATIONS THEREOF Flamel Technologies (FR) 2005-04-27 EP disclosed
EP-1511790-A1 POLYAMINOACIDS FUNCTIONALIZED BY ALPHA TOCOPHEROL AND USES THEREOF, PARTICULAR FOR THERAPEUTIC APPLICATIONS Flamel Technologies (FR) 2005-03-09 EP disclosed
WO-2004060968-A1 POLYAMINO ACIDS FUNCTIONALIZED BY AT LEAST ONE (OLIGO)AMINO ACID GROUP AND THERAPEUTIC USES FLAMEL TECHNOLOGIES (FR) 2004-07-22 WO disclosed
WO-2004013206-A2 POLYAMINO ACIDS FUNCTIONALIZED BY AT LEAST ONE HYDROPHOBIC GROUP AND THE THERAPEUTIC APPLICATIONS THEREOF FLAMEL TECHNOLOGIES (FR) 2004-02-12 WO disclosed
WO-2003104303-A1 POLYAMINOACIDS FUNCTIONALIZED BY ALPHA TOCOPHEROL AND USES THEREOF, PARTICULAR FOR THERAPEUTIC APPLICATIONS FLAMEL TECHNOLOGIES (FR) 2003-12-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080127429-A1 Coloring composition of keratinous fibers comprising at least one polysiloxane/polyurea block copolymer KRT18, PUF60, VIM ALDH1A1 2435/4885MAPT 2016/4885HPGD 3536/4885
US-11384033-B2 Compositions with improved urease-inhibiting effect comprising (thio)phosphoric acid triamide and further compounds such as amines and colorants SLC14A1, XDH, PNP ALDH1A1 1062/4885MAPT 1718/4885HPGD 1290/4885
US-20070160568-A1 Polyamino acids functionalized by at least one hydrophobic group and the therapeutic application thereof AADAT, SRM, ARG1 ALDH1A1 1535/4885MAPT 2016/4885HPGD 1931/4885
US-20070178126-A1 Polyamino acids functionalized by at least one (oligo)amino acid group and therapeutic uses DNPEP, AADAT, GLUL ALDH1A1 1369/4885MAPT 679/4885HPGD 3368/4885
US-20060099264-A1 Polyaminoacids functionalized by alpha tocopherol and uses thereof, particular for therapeutic applications TTPA, ALAD, AADAT ALDH1A1 361/4885MAPT 1203/4885HPGD 1152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.